Shareholder Lock-In: Lenskart, NSDL, eight others to see shares worth ₹30,000 crore free up this week

1 / 11

A total of 10 companies will see shares worth over ₹30,000 crore free up for trade this week as their shareholder lock-in periods expire. These include Lenskart Solutions, Orkla India, Akums Drugs, Studds Accessories, Aditya Infotech, NSDL, Sri Lotus Developers, M&B Engineering, Laxmi India Finance and Dr. Agarwal's Health Care. It must be specified that the end of the shareholder lock-in does not mean all the shares will be sold in the open market. they only become eligible to be traded.

2 / 11

Orkla India | A total of 3.4 shares of the company, or 2% of its outstanding equity, will free up for trade on February 2. At the current market price, these shares are worth ₹197 crore. The stock is 20.6% below its issue price of ₹730.

3 / 11

Studds Accessories | A total of 1.2 million shares, or 3% of its outstanding equity, will free up for trade on February 3. These shares are worth ₹58.8 crore at the present market price. The stock is 16.2% below its issue price of ₹585 per share.

4 / 11

Akums Drugs & Pharma | As many as 31.5 million shares of the company, or 20% of its outstanding equity, will free up for trade on February 3. These shares are worth ₹1,400.6 crore at the present market price. The stock is 34.5% below its IPO price of ₹679 per share.

5 / 11

Lenskart Solutions | A total of 40.7 million shares of the company, or 2% of its outstanding equity, will free up for trade on February 4. At the present market price, these shares are valued at ₹1,781 crore. The stock is up 8.9% from its issue price of ₹402 per share.

6 / 11

Aditya Infotech | According to Nuvama Alternative & Quantitative Research, as many as 74.4 million shares of the company, or 63% of its outstanding equity, will free up for trade on February 4. At the current market price, those shares are worth ₹10,359.8 crore. 

7 / 11

NSDL | As many as 149.2 million shares of NSDL, or 75% of its outstanding equity, will free up for trade on February 5. At the current market price, these shares are worth ₹14,374 crore. The stock is up 20.4% from its issue price of ₹800 apiece.

8 / 11

Sri Lotus Developers | A total of 79.3 million shares of the company, or 16% of its total outstanding shares, will see their lock-in period end on February 6. At the present market rate, these shares are worth ₹1,191 crore. The stock ended Sunday's trade session 0.2% up at ₹150.26 apiece, which is just marginally above its issue price of ₹150 per share.

9 / 11

M&B Engineering | As many as 1.6 million shares of the company, or 3% of its total outstanding shares, will free up in trade on February 6. At the present market price, these shares are worth ₹49.25 crore. The stock is 20% below its issue price of ₹385.

10 / 11

Laxmi India Finance | A total of 25.1 million shares, or 48% of its outstanding, will free up in trade on February 6. At the current market price, these are worth ₹227 crore. The stock is 42.7% below its IPO price of ₹150 per share.

11 / 11

Dr Agarwal's Health Care | As many as 36.4 million shares of the company, or 12% of its outstanding, will free up for trade on February 6. At the current market rate, these are worth ₹535.38 crore. The stock is up 10.9% from its issue price of ₹402 per share.